We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for alpelisib (Novartis Pharmaceuticals Australia Pty Ltd)
Active ingredients
alpelisib
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Genetic disorder causing excessive growth of affected tissues